Drosophila Dystroglycan is a target of O-mannosyltransferase activity of two protein O-mannosyltransferases, rotated Abdomen and Twisted

Glycobiology

Volumn 20, Issue 3, 2009, Pages 381-394

  Nakamura, Naosuke ^a   Stalnaker, Stephanie H ^b   Lyalin, Dmitry ^a   Lavrova, Olga ^a   Wells, Lance ^b   Panin, Vladsilav M ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Drosophila; Dystroglycan; Dystroglycanopathy; Glycosylation; Protein O mannosylation

Indexed keywords

DYSTROGLYCAN; GLYCOSIDASE; MANNOSE; MANNOSYLTRANSFERASE; N ACETYLGALACTOSAMINE; ROTATED ABDOMEN PROTEIN; TWISTED PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DROSOPHILA; LIGAND BINDING; MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION;

ANIMALS; DROSOPHILA; DROSOPHILA PROTEINS; DYSTROGLYCANS; MANNOSYLTRANSFERASES; MASS SPECTROMETRY;

MAMMALIA;

EID: 77949904216     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwp189     Document Type: Article

References (42)

1. Aoki K, Perlman M, Lim JM, Cantu R, Wells L, Tiemeyer M. 2007. Dynamic developmental elaboration of N-linked glycan complexity in the Drosophila melanogaster embryo. J Biol Chem. 282:9127-9142.
2. Aoki K, Porterfield M, Lee SS, Dong B, Nguyen K, McGlamry KH, Tiemeyer M. 2008. The diversity of O-linked glycans expressed during Drosophila melanogaster development reflects stage- and tissue-specific requirements for cell signaling. J Biol Chem. 283:30385-30400.
3. Barresi R, Campbell KP. 2006. Dystroglycan: From biosynthesis to pathogenesis of human disease. J Cell Sci. 119:199-207.
4. Beltran-Valero de Bernabe D, Currier S, Steinbrecher A, Celli J, van Beusekom E, van der Zwaag B, Kayserili H, Merlini L, Chitayat D, Dobyns WB et al. 2002. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet. 71:1033-1043.
5. Bendtsen JD, Nielsen H, von Heijne G, Brunak S. 2004. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol. 340:783-795.
6. Bogdanik L, Framery B, Frolich A, Franco B, Mornet D, Bockaert J, Sigrist SJ, Grau Y, Parmentier ML. 2008. Muscle dystroglycan organizes the postsynapse and regulates presynaptic neurotransmitter release at the Drosophila neuromuscular junction. PLoS ONE. 3:e2084.
7. Brand AH, Manoukian AS, Perrimon N. 1994. Ectopic expression in Drosophila. Methods Cell Biol. 44:635-654.
8. Breloy I, Schwientek T, Gries B, Razawi H, Macht M, Albers C, Hanisch FG. 2008. Initiation of mammalian O-mannosylation in vivo is independent of a consensus sequence and controlled by peptide regions within and upstream of the alpha-dystroglycan mucin domain. J Biol Chem. 283:18832-18840.
9. Christoforou CP, Greer CE, Challoner BR, Charizanos D, Ray RP. 2008. The detached locus encodes Drosophila Dystrophin, which acts with other components of the Dystrophin Associated Protein Complex to influence intercellular signalling in developing wing veins. Dev Biol. 313:519-532.
10. Deng WM, Schneider M, FrockR, Castillejo-LopezC, Gaman EA, Baumgartner S, Ruohola-Baker H. 2003. Dystroglycan is required for polarizing the epithelial cells and the oocyte in Drosophila. Development. 130:173-184.
11. Endo T. 1999. O-Mannosyl glycans in mammals. Biochim Biophys Acta. 1473:237-246.
12. Gradilone SA, Arranz SE, Cabada MO. 1998. Detection of highly glycosylated proteins in polyacrylamide gels. Anal Biochem. 261:224-227.
13. Greener MJ, Roberts RG. 2000. Conservation of components of the dystrophin complex in Drosophila. FEBS Lett. 482:13-18.
14. Haines N, Seabrooke S, Stewart BA. 2007. Dystroglycan and protein Omannosyltransferases 1 and 2 are required to maintain integrity of Drosophila larval muscles. Mol Biol Cell. 18:4721-4730.
15. Hirayama H, Fujita M, Yoko-o T, Jigami Y. 2008 O-Mannosylation is required for degradation of the endoplasmic reticulum-associated degradation substrate Gas1*p via the ubiquitin/proteasome pathway in Saccharomyces cerevisiae. J Biochem. 143:555-567.
16. Ichimiya T, Manya H, Ohmae Y, Yoshida H, Takahashi K, Ueda R, Endo T, Nishihara S. 2004. The twisted abdomen phenotype of Drosophila POMT1 and POMT2 mutants coincides with their heterophilic protein Omannosyltransferase activity. J Biol Chem. 279:42638-42647.
17. Julenius K, Molgaard A, Gupta R, Brunak S. 2005. Prediction, conservation analysis, and structural characterization of mammalian mucin-type Oglycosylation sites. Glycobiology. 15:153-164.
18. Koles K, Irvine KD, PaninVM. 2004. Functional characterization of Drosophila sialyltransferase. J Biol Chem. 279:4346-4357.
19. Koles K, Lim JM, Aoki K, Porterfield M, Tiemeyer M, Wells L, Panin V. 2007. Identification of N-glycosylated proteins from the central nervous system of Drosophila melanogaster. Glycobiology. 17:1388-1403.
20. Kucherenko MM, Pantoja M, Yatsenko AS, Shcherbata HR, Fischer KA, Maksymiv DV, Chernyk YI, Ruohola-Baker H. 2008. Genetic modifier screens reveal new components that interact with the Drosophila dystroglycan-dystrophin complex. PLoS ONE. 3:e2418.
21. Kunz S, Sevilla N, McGavern DB, Campbell KP, Oldstone MB. 2001. Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan. J Cell Biol. 155:301-310.
22. Liu J, Ball SL, Yang Y, Mei P, Zhang L, Shi H, Kaminski HJ, Lemmon VP, Hu H. 2006. A genetic model for muscle-eye-brain disease in mice lacking protein O-mannose 1, 2-N-acetylglucosaminyltransferase (POMGnT1). Mech Dev. 123:228-240.
23. Lommel M, Bagnat M, Strahl S. 2004. Aberrant processing of the WSC family and Mid2p cell surface sensors results in cell death of Saccharomyces cerevisiae O-mannosylation mutants. Mol Cell Biol. 24:46-57.
24. Lyalin D, Koles K, Roosendaal SD, Repnikova E, Van Wechel L, Panin VM. 2006. The twisted gene encodes Drosophila protein O-mannosyltransferase 2 and genetically interacts with the rotated abdomen gene encoding Drosophila protein O-mannosyltransferase 1. Genetics. 172:343-353.
25. Manya H, Chiba A, Yoshida A, Wang X, Chiba Y, Jigami Y, Margolis RU, Endo T. 2004. Demonstration of mammalian protein O-mannosyltransferase activity: Coexpression of POMT1 and POMT2 required for enzymatic activity. Proc Natl Acad Sci USA. 101:500-505.
26. Manya H, Suzuki T, Akasaka-Manya K, Ishida HK, Mizuno M, Suzuki Y, Inazu T, Dohmae N, Endo T. 2007. Regulation of mammalian protein Omannosylation: Preferential amino acid sequence for O-mannose modification. J Biol Chem. 282:20200-20206.
27. Martin PT. 2006. Mechanisms of disease: Congenital muscular dystrophiesglycosylation takes center stage. Nat Clin Pract Neurol. 2:222-230.
28. Martin PT. 2007. Congenital muscular dystrophies involving the O-mannose pathway. Curr Mol Med. 7:417-425.
29. North SJ, Koles K, Hembd C, Morris HR, Dell A, Panin VM, Haslam SM. 2006. Glycomic studies of Drosophila melanogaster embryos. Glycoconj J. 23:345-354.
30. Panin VM, Papayannopoulos V, Wilson R, Irvine KD. 1997. Fringe modulates Notch-ligand interactions. Nature. 387:908-912.
31. Proszynski TJ, Simons K, Bagnat M. 2004. O-Glycosylation as a sorting determinant for cell surface delivery in yeast. Mol Biol Cell. 15:1533-1543.
32. Rebay I, Fehon RG, Artavanis-Tsakonas S. 1993. Specific truncations of Drosophila Notch define dominant activated and dominant negative forms of the receptor. Cell. 74:319-329.
33. Rottger S, White J, Wandall HH, Olivo JC, Stark A, Bennett EP, Whitehouse C, Berger EG, Clausen H, Nilsson T. 1998. Localization of three human polypeptide GalNAc-transferases in HeLa cells suggests initiation of Olinked glycosylation throughout the Golgi apparatus. J Cell Sci. 111(Pt 1):45-60.
34. Schneider M, Khalil AA, Poulton J, Castillejo-LopezC, Egger-Adam D, Wodarz A, Deng WM, Baumgartner S. 2006. Perlecan and Dystroglycan act at the basal side of the Drosophila follicular epithelium to maintain epithelial organization. Development. 133:3805-3815.
35. Shcherbata HR, Yatsenko AS, Patterson L, Sood VD, Nudel U, Yaffe D, Baker D, Ruohola-Baker H. 2007. Dissecting muscle and neuronal disorders in a Drosophila model of muscular dystrophy. Embo J. 26:481-493.
36. Sun X, Artavanis-Tsakonas S. 1996. The intracellular deletions of Delta and Serrate define dominant negative forms of the Drosophila Notch ligands. Development. 122:2465-2474.
37. van Reeuwijk J, Janssen M, van den Elzen C, Beltran-Valero de Bernabe D, Sabatelli P, Merlini L, Boon M, Scheffer H, Brockington M, Muntoni F et al. 2005. POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome. J Med Genet. 42:907-912.
38. Wairkar YP, Fradkin LG, Noordermeer JN, DiAntonio A. 2008. Synaptic defects in a Drosophila model of congenital muscular dystrophy. J Neurosci. 28:3781-3789.
39. Wells L, Vosseller K, Cole RN, Cronshaw JM, Matunis MJ, Hart GW. 2002. Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translationalmodifications. Mol Cell Proteomics. 1:791-804.
40. Willer T, Prados B, Falcon-Perez JM, Renner-Muller I, Przemeck GK, Lommel M, Coloma A, Valero MC, de Angelis MH, Tanner W et al. 2004. Targeted disruption of the Walker-Warburg syndrome gene Pomt1 in mouse results in embryonic lethality. Proc Natl Acad Sci USA. 101:14126-14131.
41. Yoshida A, Kobayashi K, Manya H, Taniguchi K, Kano H, Mizuno M, Inazu T, Mitsuhashi H, Takahashi S, TakeuchiMet al. 2001. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell. 1:717-724.
42. Zacharius RM, Zell TE, Morrison JH, Woodlock JJ. 1969. Glycoprotein staining following electrophoresis on acrylamide gels. Anal Biochem. 30:148-152.